You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 3, March 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Salvage Surgery for Recurrent Nasopharyngeal Carcinoma

Mow-Ming Hsu, MD; Jenq-Yuh Ko, MD; Tzung-Shiahn Sheen, MD; Yen-Liang Chang, MD

Arch Otolaryngol Head Neck Surg. 1997;123(3):305-309.


Abstract

Objective
To assess the efficacy of salvage surgery for patients with recurrent nasopharyngeal carcinoma (NPC) at the primary site after radiotherapy.

Design
Retrospective analysis of 24 patients treated by transpalatal, transmaxillary, or transmandibular approach to resect the recurrent tumor, with maximum follow-up of 50 months.

Setting
Academic tertiary referral center.

Results
Radiotherapy before salvage surgery included 1 to 3 courses of radiation to the nasopharynx, with doses ranging from 60 to 190 Gy. Eighteen (75%) of the patients relapsed within 2 years, and 6 (25%) relapsed more than 6 years after the last irradiation. In 4 of 6 laterelapsing cases, the histopathological type changed to keratinizing squamous cell carcinoma, which is rare in cases of NPC in Taiwan. Fourteen patients (58%) survived for 8 to 50 months after surgery (median, 18 months). The surgical complications were tolerable.

Conclusions
Salvage surgery is feasible in selected patients with recurrent disease at the primary site. Thus, we can offer alternative retreatment in addition to external irradiation for patients with recurrent NPC.

Arch Otolaryngol Head Neck Surg. 1997;123:305-309



Author Affiliations

From the Department of Otolaryngology, College of Medicine, National Taiwan University Hospital, Taipei, Taiwan.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Chemoradiotherapy for Locally Recurrent Nasopharyngeal Carcinoma: Treatment Outcome and Prognostic Factors
Nakamura et al.
Jpn J Clin Oncol 2008;38:803-809.
ABSTRACT | FULL TEXT  

Nasopharyngectomy and Surgical Margin Status: A Survival Analysis
Vlantis et al.
Arch Otolaryngol Head Neck Surg 2007;133:1296-1301.
ABSTRACT | FULL TEXT  

Curative Surgery for Recurrent Nasopharyngeal Carcinoma via the Infratemporal Fossa Approach
Choi and Lee
Arch Otolaryngol Head Neck Surg 2005;131:213-216.
ABSTRACT | FULL TEXT  

Nasopharyngectomy After Failure of 2 Courses of Radiation Therapy
Ibrahim et al.
Arch Otolaryngol Head Neck Surg 2002;128:1196-1197.
ABSTRACT | FULL TEXT  

Nasopharyngectomy for Recurrent Nasopharyngeal Cancer: A 2- to 17-Year Follow-up
Fee et al.
Arch Otolaryngol Head Neck Surg 2002;128:280-284.
ABSTRACT | FULL TEXT  

Salvage Surgery for Recurrent Nasopharyngeal Carcinoma
Hao et al.
Arch Otolaryngol Head Neck Surg 2002;128:63-67.
ABSTRACT | FULL TEXT  

Factors Affecting the Overall Survival After Salvage Surgery in Patients With Recurrent Nasopharyngeal Carcinoma at the Primary Site: Experience With 60 Cases
Hsu et al.
Arch Otolaryngol Head Neck Surg 2001;127:798-802.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.